Neuraxpharm
Neuraxpharm is a European leader in pharmaceuticals for disorders affecting the central nervous system (CNS).
Last updated September 2, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Neuraxpharm is a European pharmaceutical company specialized in the treatment of central nervous system (CNS) disorders. It has been a specialist in this field since 1985 and its portfolio includes more than 130 molecules and 50 brands, addressing a full spectrum of psychiatric and neurological disorders. The company develops and commercializes originator brands, biologic drugs, value-added medicines, generics, medical cannabis and consumer healthcare products.
History
Neuraxpharm has been a specialist in the field of central nervous system (CNS) disorders since 1985, with 40 years of experience. It is a European leader in pharmaceuticals for CNS disorders.
Sources6 sources
- 1Home - Neuraxpharm, your CNS Specialistneuraxpharm.com
- 2CNS Pharmaceuticals - Neuraxpharmneuraxpharm.com
- 3Executive Committee - Neuraxpharmneuraxpharm.com
- 4Neuraxpharm (Germany)wikidata.org
- 5European CNS Specialist Neuraxpharm Enters Booming CBD Marketprnewswire.com
- 6Neuraxpharm acquires market-leading value-added product for emergency treatment of epileptic childrenprnewswire.com
Cite this profile: Cite the canonical profile. /brand-wiki/neuraxpharm · Editorial policy · How profiles are compiled